Building core strength through financial strategy
29 September 2011 | Joanne Payne Scrip Clinical Research
China now leads India 2:1 in clinical trials Merck Serono puts its future in Quintiles' hands Fatal flaws of trial designs: Nissen explains Japan all-in on iPS cells but where's the payoff?
FEATURES & ANALYSIS
Scrip Clinical Research Features & Analysis
Harnessing the power of flexible pharma Steady selectivity: the state of CRO consolidation in 2012 Real-world and late-phase studies in "pharmerging" markets: challenges and best practices in implementation Changing pharma industry attitudes to regulatory information management
Other Features & Analysis
Why ethically-driven compensation must be addressed alongside device regulation New tribes: the shape of medtech to come Deal making in the biosimilars market: increasing investment for decreasing return? Changing pharma industry attitudes to regulatory information management